Pfizer is by far the larger and better-established drugmaker. With a market cap of $156 billion, the pharmaceutical leader boasts a deep product portfolio across several therapeutic areas. Even with a ...
WASHINGTON — The U.S. will likely begin distributing a third vaccine against COVID-19 in the next week, and health officials are girding for questions about which one is best. The Johnson & Johnson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results